Combining Passion and Excellence
Accunea is led by a rounded group of clinicians, scientists, and experts in translational research and development
Senior Management Team
Chief Executive Officer
Dr J. Nicholas Housby
Experienced biomedical CEO and investor, track record of scaling precision medicine and genomics start-ups
Chief Financial Officer
Warren Delo
Chartered Certified Accountant, working alongside multiple innovative companies
Director Product Development
Dr Nicholas Hitchins
Highly experienced chartered engineer in product development with proven track record of delivering multiple medical devices to market
Senior Biochemist
Dr Ana Garrote Canas
Experienced scientist in the medical device industry, specialised in protein biochemistry and molecular biology assay development
Founded with a shared belief that real-time functional monitoring has the power to improve many areas of current clinical practice, where a lack of data at the point-of-care, an inability to perform predictive analysis, and a lack of population-level clinical insights are leading to sub-optimal patient outcomes.
Accunea seeks to improve confidence and safety when making critical decisions by complementing and enhancing the skills of medical professionals, enabling them to draw upon upon cutting-edge sensor technology, advanced analytics, and design.
Expert Advisory Board
Accunea is complemented and enhanced by knowledge and skills from world-leading experts in biosensing, transplantation, and renal injury
Prof. Martyn G. Boutelle
PhD ARCS
Professor of Biomedical Sensor Engineering at Imperial College London, expert in translational research
Prof. Vassilios Papalois
MD PhD FRCS
Professor of Transplant Surgery at Hammersmith Hospital, Europe's largest kidney transplant centre
Prof. Frederick WK Tam
MBBChir PhD FRCP
Ken and Mary Minton Chair of Renal Medicine at Hammersmith Hospital, expert in acute and chronic renal injury
Dr
Rob Learney
MBBChir PhD FRCP
co-inventor of Accunea's microfluidics technology board member and advisor